RE: Bernstein 1350p29 Apr 2024 10:01
On checking, I found that the HSBC analyst (I could only find one) who maintained a Sell rating on Ocado Group was Linda Shu:
She covers the Healthcare sector, focusing on stocks such as Sino Biopharmaceutical, China Medical System Holdings, and Sinopharm Group Co. She has an average return of -1.6% and a 53.33% success rate on recommended stocks.
Warehouse automation and Technology are not listed amongst her specialities and I could find no recommendations from her within the sector. I could have done some more work but it would apparently cost me a fee and, given the above, I decided it really wasn't worth pursuing, especially as HSBC's rating didn't exactly shift the dial regarding OCDO. Unsurprisingly, there doesn't seem to be any available data to back up the claim about it being a “highly competitive” market with “many established participants”. No one I've asked so far has come up with any significant suggestions beyond Autostore.